Back to search

United Kingdom· GB-APID-28693211000001104

Olsalazine 500mg tablets

A olsalazine product containing olsalazine, registered in United Kingdom by Atnahs Pharma UK Ltd. The same ATC class is registered in 11 of our 19 countries.

ATC A07EC03

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedOlsalazine 500mg tabletsATCA07EC03REGISTER NO.GB-APID-2869321100000…PACKS LISTED2CHECKEDSeptember 13, 2026

Where it is registered

Olsalazine is registered in 11 of 19 countries.

Countries holding a registration under ATC A07EC03 (olsalazine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 5 of them publish a price we can compare per daily dose

Olsalazine · ATC A07EC03

11 / 19 countries

  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of olsalazine costs, country by country.

Normalised to the WHO defined daily dose (1 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Olsalazine · price per daily dose (1 g)

USD · FX 28 Sept 2026

  • FR France$1.44
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Olsalazine
Manufacturer
Atnahs Pharma UK Ltd
Country
United Kingdom (GB)
ATC code
A07EC03
ATC class
Olsalazine
Defined daily dose
1 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    5021730030056
  • gtin
    05056227200407

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

110 interactions on record for olsalazine.

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Olsalazine · interactions on record

110 records

  • 15 severe
  • 93 moderate
  • 2 minor

Most severe, free to view

  • CidofovirJ05AB12severe
  • Humane Immunglobuline, unspezifisch, extravaskulärJ06BA01severe
  • Humane Immunglobuline, unspezifisch, intravaskulärJ06BA02severe
  • SirolimusL01EG04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Olsalazine in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All olsalazine products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Germany · Dipentum
  • Denmark · Dipentum
  • Finland · Dipentum
  • France · Dipentum
  • Ireland · Dipentum
  • Iceland · Dipentum
  • Netherlands · Dipentum
  • Norway · Dipentum
  • Sweden · Dipentum

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d175eed2-b9f0-493e-9aa4-17bb65e047df
GET /v1/drugs/d175eed2-b9f0-493e-9aa4-17bb65e047df?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "28693211000001104",
  "desc": "Olsalazine 500mg tablets (Atnahs Pharma UK Ltd)",
  "form": "Oral tablet",
  "vpid": "42356111000001107",
  "source": "dmd",
  "vtm_id": "776986001",
  "strength": "500 mg",
  "substance": "Olsalazine",
  "ingredient": "Olsalazine sodium",
  "supplier_code": "28790911000001109"
}

See everything about olsalazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.